Nhung Nguyen, PhD, received her doctorate in Epidemiology from The University of Texas Health Science Center at Houston, TX, and her BS in Pharmacy from Hanoi University of Pharmacy, Vietnam. Her dissertation was among the first to examine smoking prevalence, nicotine dependence, and related factors among HIV-positive people in Vietnam. Her research interests include application of technology and data science in smoking cessation intervention among smokers with polysubstance use, and in smoking prevention among youth and young adults.
Research program includes clinical and basic science approaches to study the effects of cigarette smoke on lung inflammation. He is also the Principal Investigator on the NIH-funded Spiromics Project and a Co-investigator on the COPD Clinical Research Network. Dr. Woodruff received his B.A, from Wesleyan University in 1989, received his M.D. degree from the Columbia College of Physicians and Surgeons in 1993, and completed Internal Medicine residency training at the Massachusetts General Hospital.
My research focuses on tobacco use in vulnerable populations, with a particular emphasis on interventions with the homeless population. My population-based research includes the analysis of cross-sectional and longitudinal data, including the analysis of national data, to examine the use of novel tobacco products and the efficacy of tobacco control policies on reducing tobacco use in low-income populations.
The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.
Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation. Dr.
Dr. Schroeder is Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine, UCSF, where he also heads the Smoking Cessation Leadership Center. The Center, funded by the Robert Wood Johnson Foundation and the Truth Initiative, works with leaders of more than 80 American health professional organizations and health care institutions to increase the cessation rate for smokers.
I study the health effects of air pollution in human subjects. I focus on the chemistry and toxicity of smoke and on how exposure to tobacco or cannabis smoke can cause heart and lung disease. My analysis of tobacco industry research showed that sidestream cigarette smoke (the primary constituent of secondhand cigarette smoke) is more toxic than the smoke that smokers inhale and that secondhand smoke becomes more toxic as it ages.
Jason M. Satterfield is past Academy Endowed Chair for Innovation in Teaching, Director of Behavioral Medicine and Professor of Clinical Medicine in the Division of General Internal Medicine at the University of California San Francisco. He received his B.S. in brain sciences from MIT and his Ph.D. in clinical psychology from the University of Pennsylvania. Dr.
